When to discharge children hospitalized with pertussis?

Gideon Lurie1, Peter W Reed, Cameron C Grant

  • 1General Pediatrics, Starship Children's Hospital, Auckland District Health Board, Auckland, New Zealand.

Academic Pediatrics
|March 31, 2009
PubMed

Insights

Clinical signs like paroxysmal cough and cyanosis can help determine safe discharge for children hospitalized with pertussis. These symptoms indicate a higher risk of readmission, guiding clinical decisions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Determining safe discharge for hospitalized pertussis patients is challenging.
  • Identifying predictors of readmission is crucial for optimizing patient care and resource allocation.

Purpose of the Study:

  • To identify clinical features associated with readmission in children hospitalized with pertussis.
  • To inform clinical decision-making regarding discharge timing for pediatric pertussis patients.

Main Methods:

  • A case series design was employed, analyzing data from 207 children hospitalized with pertussis.
  • Readmitted children (n=33) were compared to non-readmitted children (n=174) to identify risk factors.

Main Results:

  • No significant differences in demographics or immunization status were found between readmitted and non-readmitted groups.
  • Children readmitted for pertussis experienced more cyanotic episodes per day and on a greater proportion of hospital days.
  • Increased risk of readmission was associated with frequent cyanotic episodes and paroxysmal coughing on the last day of admission.

Conclusions:

  • Paroxysmal cough and cyanosis are significant clinical indicators for predicting pertussis readmission in children.
  • These clinical signs can aid healthcare providers in making informed decisions about when to safely discharge children from the hospital.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...